Barrett Elizabeth A.
SEC CIK 1764157 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| URGN | UroGen Pharma Ltd. | CEO | 313.4K | — | $491.9K | 7 | 2020-02-03 | 2023-01-31 |
Most active insiders at URGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schoenberg Mark | Chief Medical Off | — | $4.48M |
| 2 | Smith Jason Drew | GC | — | $211.9K |
| 3 | Degnan Chris | CFO | — | $37.1K |
| 4 | Wildman Daniel George | Dir | — | — |
| 5 | WEN LEANA | Dir | — | — |
| 6 | Holden Stuart | Dir | — | — |
| 7 | Robinson James A. Jr. | Dir | — | — |
| 8 | BUTITTA CYNTHIA M | Dir | — | — |
Barrett Elizabeth A. made no open-market trades at URGN in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-02 | 2023-01-31 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | CEO | M - OptEx | — | +18.3K | 313.4K | +6% | — |
| DM | 2022-02-02 | 2022-01-31 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | CEO | S - Sale+OE | $7.58 | -8,195 | 301.0K | -3% | -$62.1K |
| DM | 2022-02-02 | 2022-01-31 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | CEO | M - OptEx | — | +18.3K | 314.3K | +6% | — |
| D | 2022-01-07 | 2022-01-03 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | CEO | M - OptEx | — | +105.7K | 345.2K | +44% | — |
| D | 2022-01-07 | 2022-01-04 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | CEO | S - Sale+OE | $9.15 | -47.0K | 298.2K | -14% | -$429.8K |
| DMA | 2021-07-12 | 2020-06-03+ | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | CEO | M - OptEx | — | +61.7K | 166.3K | +59% | — |
| DMA | 2021-07-12 | 2020-02-03+ | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | CEO | M - OptEx | — | +35.2K | 131.0K | +37% | — |
Purchase Sale Sale after option exercise All abbreviations